What Are Metabolic Peptides?
Metabolic peptides are research compounds that interact with key metabolic signaling pathways in the body. These peptides are studied in laboratory settings for their effects on glucose homeostasis, energy expenditure, insulin sensitivity, appetite regulation, and body composition.
The most extensively researched metabolic peptides include GLP-1 receptor agonists (Semaglutide), dual GIP/GLP-1 agonists (Tirzepatide), triple agonists (Retatrutide), mitochondrial peptides (MOTS-C), and GHRH analogs (Tesamorelin). Each class operates through distinct receptor pathways affecting metabolic regulation.
Key Research Areas: Glucose metabolism, insulin signaling pathways, energy expenditure mechanisms, appetite regulation, adipose tissue metabolism, mitochondrial function, and visceral fat reduction.
Peptide Mechanisms
GLP-1 Agonists
Single receptor activation for appetite and glucose regulation.
Examples: Semaglutide
Dual Agonists
GIP/GLP-1 receptor activation for enhanced metabolic effects.
Examples: Tirzepatide
Triple Agonists
GIP/GLP-1/Glucagon activation for maximum metabolic modulation.
Examples: Retatrutide
Mitochondrial Peptides
Cellular energy homeostasis and metabolic regulation.
Examples: MOTS-C
Peptide Comparison
| Peptide | Receptor Targets | Primary Research Focus | Half-Life |
|---|---|---|---|
| Retatrutide | GIP/GLP-1/Glucagon | Triple receptor metabolic signaling | ~5-7 days |
| Tirzepatide | GIP/GLP-1 | Dual receptor metabolic pathways | ~5 days |
| Semaglutide | GLP-1 | Appetite regulation, glucose metabolism | ~7 days |
| MOTS-C | Mitochondrial signaling | Metabolic regulation, insulin sensitivity | ~2-3 hours |
| Tesamorelin | GHRH receptor | Visceral fat metabolism, IGF-1 production | 26-38 minutes |
Research Compounds
Retatrutide
Mechanism: Triple GIP/GLP-1/Glucagon receptor agonist
Research: Metabolic signaling, energy expenditure, body composition
Tirzepatide
Mechanism: Dual GIP/GLP-1 receptor agonist
Research: Metabolic pathways, insulin sensitivity, adipose tissue
Semaglutide
Mechanism: GLP-1 receptor agonist
Research: Appetite regulation, glucose metabolism, weight management
MOTS-C
Mechanism: Mitochondrial-derived peptide
Research: Metabolic regulation, insulin sensitivity, energy homeostasis
Tesamorelin
Mechanism: GHRH receptor activation
Research: Visceral fat metabolism, IGF-1 production
Frequently Asked Questions
What are metabolic peptides?
Metabolic peptides are research compounds that interact with metabolic signaling pathways, including GLP-1 receptors, GIP receptors, GHRH receptors, and mitochondrial signaling. They are studied for their effects on glucose metabolism, energy expenditure, insulin sensitivity, and body composition.
What is the difference between GLP-1 and GIP peptides?
GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) are incretin hormones that regulate glucose metabolism. GLP-1 primarily affects appetite and insulin secretion, while GIP influences insulin release and fat metabolism. Dual agonists like Tirzepatide target both receptors.
What makes Retatrutide unique?
Retatrutide is a triple agonist that activates GIP, GLP-1, and glucagon receptors. This triple mechanism is studied for its potential synergistic effects on metabolic pathways, energy expenditure, and body composition compared to single or dual agonists.
What is MOTS-C peptide?
MOTS-C is a mitochondrial-derived peptide encoded in the mitochondrial genome. It is studied for its role in metabolic regulation, insulin sensitivity, cellular energy homeostasis, and longevity pathways in laboratory research.